These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10144477)

  • 1. FTC approves Lilly's PCS purchase.
    Scott L
    Mod Healthc; 1995 Aug; 25(32):30. PubMed ID: 10144477
    [No Abstract]   [Full Text] [Related]  

  • 2. Lilly purchase of PCS awaits FTC clearance.
    Scott L
    Mod Healthc; 1994 Oct; 24(44):29. PubMed ID: 10138146
    [No Abstract]   [Full Text] [Related]  

  • 3. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 4. Feds state their case. FTC: deals would end distributors' incentive to cut prices.
    Hensley S
    Mod Healthc; 1998 Mar; 28(11):28. PubMed ID: 10178255
    [No Abstract]   [Full Text] [Related]  

  • 5. Hoechst plans divestitures to gain FTC nod.
    Scott L
    Mod Healthc; 1995 Sep; 25(39):32. PubMed ID: 10151416
    [No Abstract]   [Full Text] [Related]  

  • 6. Playing monopoly? FTC probes mammoth drug distributor merger.
    Becker C
    Mod Healthc; 2001 May; 31(20):34. PubMed ID: 11386133
    [No Abstract]   [Full Text] [Related]  

  • 7. Lilly deal's timing drew FTC notice.
    Scott L
    Mod Healthc; 1994 Oct; 24(43):8. PubMed ID: 10138136
    [No Abstract]   [Full Text] [Related]  

  • 8. Too big? Caremark, AdvancePCS getting close look from feds.
    Becker C
    Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA
    Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
    [No Abstract]   [Full Text] [Related]  

  • 10. Lilly's acquisition of PCS provides new tool for sales.
    Scott L
    Mod Healthc; 1994 Jul; 24(29):22. PubMed ID: 10135054
    [No Abstract]   [Full Text] [Related]  

  • 11. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 12. Will antitrust cops bust billion-dollar drug deals?
    Barnett AA
    J Am Health Care; 1994; 4(5):5-7. PubMed ID: 10142816
    [No Abstract]   [Full Text] [Related]  

  • 13. FTC approves two-way merger in Maine.
    Burda D
    Mod Healthc; 1995 Mar; 25(12):17. PubMed ID: 10140672
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitrust enforcement in pharmaceutical industry mergers.
    Balto DA; Mongoven JF
    Food Drug Law J; 1999; 54(3):255-78. PubMed ID: 11797700
    [No Abstract]   [Full Text] [Related]  

  • 15. Good Samaritan, FTC settle 4-year dispute.
    Burda D
    Mod Healthc; 1994 Sep; 24(37):6. PubMed ID: 10136428
    [No Abstract]   [Full Text] [Related]  

  • 16. The wake of FTC v. Actavis: practical implications on the pharmaceutical industry.
    Ritter M; Tempesta J; Ragusa P
    Pharm Pat Anal; 2014 Jul; 3(4):345-7. PubMed ID: 25291307
    [No Abstract]   [Full Text] [Related]  

  • 17. FTC probe centers on Phoenix hospital, physicians.
    Burda D
    Mod Healthc; 1991 Jun; 21(24):4. PubMed ID: 10110987
    [No Abstract]   [Full Text] [Related]  

  • 18. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 19. The FTC v. Actavis roadmap: a guide to properly applying the rule of reason standard in reverse payment cases.
    Sharkey N
    J Leg Med; 2014; 35(3):445-66. PubMed ID: 25207633
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.